Giulia C Kennedy Veracyte, Inc. (VCYT) insider trading activity

Giulia C Kennedy is Chief Scientific & Med Officer of VERACYTE, INC.. Currently has a direct ownership of 65,970 shares of VCYT, which is worth approximately $2.41 Million. The most recent transaction as insider was on Dec 06, 2022, when has been sold 1,023 shares (Common Stock) at a price of $27.03 per share, resulting in proceeds of $27,651. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66K

0% 3M change

0% 12M change

Total Value Held $2.41 Million

Giulia C Kennedy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 06 2022	SELL Open market or private sale	$27,651 $27.03 p/Share	1,023 Reduced 1.53%	65,970 Common Stock
Dec 02 2022	SELL Payment of exercise price or tax liability	$29,373 $29.14 p/Share	1,008 Reduced 1.48%	66,993 Common Stock
Nov 11 2022	SELL Open market or private sale	$58 $29.34 p/Share	2 Reduced 0.0%	68,001 Common Stock
Nov 11 2022	BUY Exercise of conversion of derivative security	$28 $14.34 p/Share	2 Added 0.0%	68,003 Common Stock
Nov 04 2022	SELL Open market or private sale	$25,575 $25.0 p/Share	1,023 Reduced 1.48%	68,001 Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$19,333 $19.18 p/Share	1,008 Reduced 1.44%	69,024 Common Stock
Aug 05 2022	SELL Open market or private sale	$27,283 $26.54 p/Share	1,028 Reduced 1.45%	70,032 Common Stock
Aug 05 2022	BUY Exercise of conversion of derivative security	$37 $7.44 p/Share	5 Added 0.01%	71,060 Common Stock
Aug 05 2022	BUY Grant, award, or other acquisition	-	10,702 Added 13.09%	71,055 Common Stock
Jun 02 2022	SELL Payment of exercise price or tax liability	$18,376 $18.23 p/Share	1,008 Reduced 1.64%	60,353 Common Stock
Mar 04 2022	SELL Open market or private sale	$591,177 $25.7 p/Share	23,003 Reduced 27.26%	61,391 Common Stock
Mar 04 2022	BUY Exercise of conversion of derivative security	$26,354 $5.98 p/Share	4,407 Added 4.96%	84,394 Common Stock
Mar 03 2022	BUY Grant, award, or other acquisition	-	42,412 Added 34.65%	79,987 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$287,782 $27.84 p/Share	10,337 Reduced 21.57%	37,575 Common Stock
Dec 07 2021	SELL Open market or private sale	$248,797 $40.62 p/Share	6,125 Reduced 11.33%	47,912 Common Stock
Dec 07 2021	BUY Exercise of conversion of derivative security	$156,923 $25.62 p/Share	6,125 Added 10.18%	54,037 Common Stock
Dec 06 2021	SELL Open market or private sale	$334,660 $36.25 p/Share	9,232 Reduced 16.16%	47,912 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$106,844 $13.1 p/Share	8,156 Added 12.49%	57,144 Common Stock
Dec 02 2021	SELL Payment of exercise price or tax liability	$35,769 $39.22 p/Share	912 Reduced 1.83%	48,988 Common Stock
Nov 01 2021	SELL Payment of exercise price or tax liability	$7,718 $51.8 p/Share	149 Reduced 0.3%	49,900 Common Stock
Sep 08 2021	SELL Open market or private sale	$46,791 $50.53 p/Share	926 Reduced 1.82%	50,049 Common Stock
Sep 07 2021	SELL Open market or private sale	$637,577 $50.88 p/Share	12,531 Reduced 19.73%	50,975 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$212,526 $16.96 p/Share	12,531 Added 16.48%	63,506 Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$48,309 $52.97 p/Share	912 Reduced 1.76%	50,975 Common Stock
Jun 23 2021	SELL Open market or private sale	$173,906 $39.75 p/Share	4,375 Reduced 7.78%	51,887 Common Stock

GCK

Giulia C Kennedy

Chief Scientific & Med Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCYT shares.

Notify only if

Value

Insider Trading

Get notified when an Veracyte, Inc. insider buys or sells VCYT shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERACYTE, INC.

Track Activities on VCYT

Account